A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines

NCT01749410 · clinicaltrials.gov ↗

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Migraine, Headaches

Interventions

BIOLOGICAL: onabotulinumtoxinA

Sponsor

Allergan